Business—14 Oct 2025

South African healthcare comparison: Aspen, Netcare, Life Healthcare, and Adcock Ingram

The South African healthcare sector has experienced turbulent times in recent years, and the companies operating in this space have struggled to show share price growth.

While the private healthcare sector in South Africa is often seen as well-resourced and high-quality compared to the public sector, it has had many struggles in recent years.

The challenges are partly systemic, partly economic, and increasingly shaped by political and regulatory pressures.

Private healthcare in South Africa is costly, and the prices have been rising faster than inflation for years. This, in turn, put pressure on all players.

South Africa’s slow economic growth and high unemployment have also affected medical scheme membership, which has stagnated.

Only a small portion of South Africans are on medical aid, and that number has stagnated, which puts pressure on the schemes.

Another destabilising factor is the National Health Insurance (NHI) Bill, which aims to centralise healthcare funding under the state and make healthcare universal.

It has created significant uncertainty for the private sector, particularly for private hospitals and clinics, health insurers, and medical professionals.

The state has also increased the administrative and compliance burden on private healthcare providers, which incur additional costs.

Although not all private healthcare companies are equally affected by these factors, they all struggled with share price growth in 2025.

Many investors consider sectors instead of individual companies in their investment decisions, which means that changes can affect all companies in a sector.

However, individual factors still have the most significant impact on the share price. Aspen is a good example in the local market.

Aspen Pharmacare has swung to a loss in its 2025 financial year, as significant impairments weighed on its earnings.

This is reflected in its share price, which has performed much worse than its peers in 2025.

The tables and chart below provide an overview of the performance of South African healthcare companies in 2025.